CGI files 2025 Annual Disclosure Documents
Stock Market SymbolsGIB.A (TSX)GIB (NYSE)cgi.com/newsroom MONTRÉAL, Dec. 17, 2025 /PRNewswire/ – CGI (TSX: GIB.A) (NYSE: GIB) has filed with the securities... Read more.
AAR to acquire Aircraft Reconfig Technologies, expanding its engineering and certification capabilities and creating additional revenue streams
The acquisition continues AAR’s accelerated growth strategy through M&A WOOD DALE, Ill., Dec. 17, 2025 /PRNewswire/ — AAR CORP. (NYSE: AIR), a leading... Read more.
The Next Era of Industry Will Be Defined by Ecosystems, Autonomy, and Accelerated Competition, Says Info-Tech Research Group
As rapid advances in AI, autonomous operations, and connected value chains reshape every sector, many organizations still lack the structured foresight needed to... Read more.
Truvista Fiber Acquires SlyTel
CHESTER, S.C., Dec. 17, 2025 /PRNewswire/ — Truvista Fiber announced today the acquisition of SlyTel, a municipal telecommunications company located in Sylvester,... Read more.
Clywedog Therapeutics Announces Activation of All Centers and Patient Dosing in Multicenter, International Phase 1b Clinical Study of Balomenib in Type 2 Diabetes
DOVER, Del., Dec. 17, 2025 /PRNewswire/ — Clywedog Therapeutics, Inc., a clinical-stage biotechnology company advancing novel therapies for metabolic diseases,... Read more.
Brasswater Acquires Mont Tremblant Retail Village, One of Canada’s Premier Four-Season Destinations
MONTREAL, Dec. 17, 2025 /PRNewswire/ – Brasswater, a leading private real estate investment and development firm, announced today that it has completed the... Read more.
OnePay and Greenshades Partner to Bring Financial Wellness to Millions of Frontline Workers
Greenshades to embed direct access to OnePay’s financial wellness tools in its platform NEW YORK, Dec. 17, 2025 /PRNewswire/ — OnePay, the leading consumer... Read more.
Equifax Secures 27 New Patents in the Second Half of 2025
20 Patents Support the Organization’s Approach to Responsible AI, Designed to Accelerate Product Innovation that Help to Create New Financial Opportunities... Read more.
Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development
DOVER, Del., Dec. 17, 2025 /PRNewswire/ — Eilean Therapeutics announced the advancement of ZE74-0282 into first-in-human clinical development. ZE74-0282 is... Read more.
Jazz Pharmaceuticals to Participate in Upcoming Investor Events
DUBLIN, Dec. 17, 2025 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor events:... Read more.